<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Circadian rhythm of 6-sulphatoxymelatonin (aMT6s) excretion has been studied in <z:hpo ids='HP_0012126'>stomach cancer</z:hpo> (n = 89) and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (n = 86) patients </plain></SENT>
<SENT sid="1" pm="."><plain>The excretion of aMT6s was decreased in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>The disturbances of the circadian rhythm of aMT6s excretion have been observed in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients as well </plain></SENT>
<SENT sid="3" pm="."><plain>These changes were directly proportional to the extent of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> process and to the extent of lymphogenic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
</text></document>